High Margins Meet Valuation Tension
Slightly undervaluedDCF
Equity analysis

CME Group Inc (CME) High Margins Meet Valuation Tension

Apr 6, 2026Equity Analysis

Is the current price already assuming durable exchange economics?

Trailing P/E
26.87
Price
305.11
ROE
14.58
Gross Margin
95.97

How Does This Market Operator Earn?

CME Group runs marketplaces where financial contracts are traded and cleared. It earns revenue from activity tied to those markets, supported by the infrastructure around trading and post-trade services. The business sits inside financial services, with a scale that places it among the larger public companies in the space at about USD 109.4 billion in market value. Its role is less about taking market risk and more about operating the venue and systems that others rely on.

Are Margins And Cash Flow Holding Up?

Fundamentals

For 2025, reported in USD, revenue was USD 6.5 billion, alongside EBIT of USD 4.2 billion and net income of USD 4.1 billion. Revenue grew 6.4% versus the prior year, with trailing margins remaining very high, including a 95.97% gross margin and an 81.31% operating margin.

Cash on the balance sheet was USD 4.4 billion against total debt of USD 3.4 billion. A cash flow proxy of about USD 3.2 billion (built from after-tax EBIT plus depreciation and amortization, less capital spending, and excluding working-capital changes) sits alongside depreciation and amortization of USD 223.4 million.

Is The Market Overpaying For Stability?

DCF / Multiples

At USD 305.11, the share price sits above the weaker fair-value outcome but well below the central and stronger outcomes from the DCF range. The headline multiples—about 26.87x trailing earnings and 19.85x EV/EBITDA—frame the stock as priced for a business that can keep producing substantial profits relative to revenue.

Constructive But Valuation Sensitive

Takeaway

CME looks built around durable, fee-driven market infrastructure. The current pricing still leaves room for a wide range of outcomes. The case works best if margins and cash generation stay elevated. It weakens if profitability compresses or growth fades. Overall, the setup leans constructive, but not without valuation risk.

Disclaimer
This analysis is for informational purposes only and does not constitute investment advice.
Fair Value Rankings

Market Price vs Intrinsic Value

Quick access to the most undervalued and overvalued stocks, ranked by their discount or premium to DCF-based fair value.

Undervalued

Stocks trading below fair value

View full ranking
1
Delta Air Lines Inc
DAL
+80%
discount
2
Brown & Brown Inc
BRO
+79%
discount
3
Verizon Communications Inc
VZ
+78%
discount
Overvalued

Stocks trading above fair value

View full ranking
1
Bank of America Corp
BAC
+393%
premium
2
Applied Materials Inc
AMAT
+392%
premium
3
Guidewire Software Inc
GWRE
+391%
premium
INDEX
VDIX
ValueDetect Intrinsic eXpectations Index
Overvalued market
View index

VDIX measures whether the market is expensive or cheap relative to intrinsic value. For each company, ValueDetect estimates fair value using a discounted cash flow (DCF) model, then compares it with the current share price to derive a RiskRatio. These signals are capped, weighted by market capitalization, and aggregated into a single market-wide score.

Current score-0.82Negative = market trades above fair value
1-day move-0.13Rising score = improving valuation conditions
7-day average-0.68Smoothed market valuation signal
Latest observation03 June 2026The latest weighted reading suggests that the market is trading above DCF-based intrinsic value in aggregate.
Next actions

What would you like?

Continuously expanding company coverage — prioritized by user demand.

Suggest a company to analyze

Help shape what we analyze next.

We'll send a confirmation email to verify your request — not for marketing.

New analyses are added regularly. Request processing times may vary.